Skip to main content
Clinical Trials/PACTR202304775359949
PACTR202304775359949
Not yet recruiting
Phase 2

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia after Knee Surgeries

Faculty of Medicine Kafr Elsheikh University0 sites70 target enrollmentMarch 25, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Orthopaedics
Sponsor
Faculty of Medicine Kafr Elsheikh University
Enrollment
70
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 25, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Medicine Kafr Elsheikh University

Eligibility Criteria

Inclusion Criteria

  • Patient’s approval.
  • Age: 30 – 65years.
  • Sex: Both males and females.
  • Physical Status: American Society of Anesthesiologists
  • (ASA) I \& II.

Exclusion Criteria

  • Patient refusal
  • Age: \>65 and \<30 years.
  • Allergy to Dexmedetomidine, local anesthetics, systemic opioids and any of the drugs included in the multimodal perioperative pain protocol.
  • Revision surgery.
  • Patients with impaired kidney functions and coagulopathy.
  • Chronic pain syndromes and patients with chronic opioid use defined as use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery.
  • BMI of 40 or more.
  • Physical Status: American Society of Anesthesiologists (ASA) III \& IV.

Outcomes

Primary Outcomes

Not specified

Similar Trials